Hilo by Aktiia

- 15/05/2025
- Series B
- $42,000,000
Aktiia, now trading under Hilo, was established in 2018 to transform how blood pressure is measured and therefore managed.
Hilo is transforming blood pressure monitoring with cuffless, AI-powered technology that delivers continuous, accessible insights for individuals and healthcare professionals. Our foundation model is trained on billions of optical signals and hundreds of millions of readings from over 120,000 users—one of the largest datasets in the field. Backed by a multidisciplinary team with deep expertise in biomedical signal processing, Hilo has contributed to over 120 peer-reviewed publications and holds more than 35 patents. Headquartered in Switzerland, we’re expanding globally to redefine how blood pressure is measured and managed.
- Industry Home Health Care Services
- Website https://hilo.com/uk/
- LinkedIn https://www.linkedin.com/company/hilohealth/
Related People
Raghav (Rags) GuptaFounder

CEO at Aktiia. Entrepreneur and operator at 5 startups over the past 20 years including 1 IPO and 1 acquisition. Operating partner at Hyperplane.